Last updated: June 6, 2026
Executive summary: No complete, verifiable supplier/APIsource map for “HEPZATO” can be produced from the information available in this session. Without a confirmed active ingredient, dosage form, and market authorization identifiers, any supplier list would be speculative.
What companies supply HEPZATO in the US or EU?
A supplier map for HEPZATO requires a confirmed product definition (active ingredient(s), strength, dosage form, and marketing authorization holder or labeler). “HEPZATO” is used as a trade name in multiple jurisdictions for different products, and “supplier” can mean labeler, MAH, contract manufacturer, or API producer.
How to identify the real HEPZATO supplier quickly
For each geography, the authoritative source is typically:
- FDA labeler/MAH and manufacturing site(s (DailyMed/label)
- Orange Book listing (if the product is an NDA/ANDA drug)
- EMA EPAR and PL
- Commercial pack insert (SmPC/PI) for EU
- GMP manufacturing site disclosures in regulatory filings
What is the active ingredient and which firms manufacture that API used in HEPZATO?
Supplier lists depend on the API identity. For a hyaluronate-related product, the API vendor and fermentation or extraction route affect sourcing risk (single vs multiple qualified suppliers).
API supply risk drivers for hyaluronate-type actives
- Single geography sourcing for raw materials (e.g., fermentation inputs)
- Unique molecular weight distribution requirements
- Sterility/bioburden controls and filtration compatibility
- Contract manufacturing dependencies for aseptic filling
What contract manufacturing organizations (CMOs) make HEPZATO finished product?
Finished-product suppliers are usually the labeler plus listed manufacturing facilities. The CMO name can appear as:
- “Manufactured for” / “Manufactured by” on the US label
- Site-specific manufacturing sections in EMA documentation
- NDA/DMF references linked to the product application
What to extract from packaging and regulatory labels
- Contract fill-finish sites (aseptic vs terminal)
- Sterility assurance method
- Primary packaging compatibility controls
- Release testing locations
What is the Orange Book status of HEPZATO and which suppliers are listed?
Orange Book coverage requires a recognized NDA holder and an FDA product identifier. The supplier names that matter for exclusivity and generic entry are the NDA holder and any listed patents.
What you should expect to find if HEPZATO is listed
- NDA number
- Active ingredient(s)
- Dosage form and route
- Patent numbers (drug substance, drug product, method-of-use)
- Exclusivity start and end dates
How many suppliers cover HEPZATO and what are the back-up manufacturing sites?
A robust supplier picture usually includes:
- Primary manufacturing site
- Secondary/backup CMOs
- API backup producers
- Qualified interchangeability statements in quality agreements
Supply chain bottleneck checks
- Single fill-finish location
- One sterile filtration or fill line
- Limited supplier acceptance for substitution of container closure systems
Which distributors supply HEPZATO to hospitals and wholesalers?
Wholesaler and hospital distribution channels are distinct from manufacturing suppliers. Distribution depends on:
- WAC pricing and reimbursement strategy
- Hospital group purchasing agreements
- Authorized distributor networks
What “supplier” means in procurement workflows
- MAH (manufacturer of record)
- Product distributor (wholesaler)
- GPO contract holder
- Specialty distributor (if applicable)
What patent estate or regulatory constraints affect who can supply HEPZATO?
If HEPZATO is under exclusivity, licensing, or patent protection, supplier eligibility can be constrained:
- Approved manufacturing processes
- Licensed IP for formulation or method-of-use
- DMF-linked drug substance controls
What to check for supplier transfer barriers
- Proprietary analytical method packages
- Sterile process validation IP
- Stability and shelf-life justification ownership
Key Takeaways
- A validated supplier list for “HEPZATO” cannot be generated from the available inputs because “HEPZATO” is a trade name that must be tied to a specific active ingredient and regulatory product record.
- Any correct supplier answer must be anchored to the product labeler/MAH and the listed manufacturing sites in FDA/EMA sources.
FAQs
- How do I find the finished-product manufacturer for HEPZATO from the label?
- Does HEPZATO’s Orange Book listing include patent numbers and exclusivity dates?
- Who supplies the active ingredient used in HEPZATO?
- Are there multiple qualified manufacturing sites for HEPZATO to mitigate shortages?
- Which document sections typically disclose the contract fill-finish sites for HEPZATO?
References
No sources were cited because no verifiable product definition or regulatory record for “HEPZATO” was provided or available in this session.
